IL179349A0 - 3-[4-{6-(substituted alkanoyl)pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents - Google Patents

3-[4-{6-(substituted alkanoyl)pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents

Info

Publication number
IL179349A0
IL179349A0 IL179349A IL17934906A IL179349A0 IL 179349 A0 IL179349 A0 IL 179349A0 IL 179349 A IL179349 A IL 179349A IL 17934906 A IL17934906 A IL 17934906A IL 179349 A0 IL179349 A0 IL 179349A0
Authority
IL
Israel
Prior art keywords
oxazolidin
triazol
ylmethyl
pyridin
ones
Prior art date
Application number
IL179349A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Zhou Fei
Gravestock Michael Barry
Reck Folkert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0411593A external-priority patent/GB0411593D0/en
Priority claimed from GB0500054A external-priority patent/GB0500054D0/en
Application filed by Astrazeneca Ab, Zhou Fei, Gravestock Michael Barry, Reck Folkert filed Critical Astrazeneca Ab
Publication of IL179349A0 publication Critical patent/IL179349A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL179349A 2004-05-25 2006-11-16 3-[4-{6-(substituted alkanoyl)pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents IL179349A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0411593A GB0411593D0 (en) 2004-05-25 2004-05-25 Chemical compounds
GB0500054A GB0500054D0 (en) 2005-01-05 2005-01-05 Chemical compounds
PCT/GB2005/002051 WO2005116022A1 (en) 2004-05-25 2005-05-24 3- `4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents

Publications (1)

Publication Number Publication Date
IL179349A0 true IL179349A0 (en) 2007-03-08

Family

ID=34968778

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179349A IL179349A0 (en) 2004-05-25 2006-11-16 3-[4-{6-(substituted alkanoyl)pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents

Country Status (10)

Country Link
US (1) US20080021012A1 (enExample)
EP (1) EP1753754A1 (enExample)
JP (1) JP2008500317A (enExample)
AU (1) AU2005247668A1 (enExample)
BR (1) BRPI0511526A (enExample)
CA (1) CA2566963A1 (enExample)
IL (1) IL179349A0 (enExample)
MX (1) MXPA06013537A (enExample)
NO (1) NO20065889L (enExample)
WO (1) WO2005116022A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
EP2346858B1 (en) * 2008-10-10 2019-08-07 Merck Sharp & Dohme Corp. Methods for preparing oxazolidinones and compositions containing them
UA114068C2 (xx) 2009-02-03 2017-04-25 Кристалічні частинки (r)-3-(4-(2-(2-метилтетразол-5-іл)піридин-5-іл)-3-фторфеніл)-5-гідроксиметилоксазолідин-2-ондиводеньфосфату
US8580767B2 (en) * 2009-05-28 2013-11-12 Trius Therapeutics, Inc. Oxazolidinone containing dimer compounds, compositions and methods to make and use
KR101561964B1 (ko) 2013-11-15 2015-10-20 한국과학기술연구원 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물
JP6864379B2 (ja) 2016-03-31 2021-04-28 オンターナル セラピューティック インコーポレイテッドＯｎｃｔｅｒｎａｌ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． インドール類似体及びその使用
US11555033B2 (en) 2020-06-18 2023-01-17 Akagera Medicines, Inc. Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6689779B2 (en) * 2000-06-05 2004-02-10 Dong A Pharm. Co., Ltd. Oxazolidinone derivatives and a process for the preparation thereof
US7473699B2 (en) * 2002-02-28 2009-01-06 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents

Also Published As

Publication number Publication date
NO20065889L (no) 2007-02-20
MXPA06013537A (es) 2007-01-26
BRPI0511526A (pt) 2007-12-26
JP2008500317A (ja) 2008-01-10
WO2005116022A1 (en) 2005-12-08
US20080021012A1 (en) 2008-01-24
AU2005247668A1 (en) 2005-12-08
EP1753754A1 (en) 2007-02-21
CA2566963A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
SI1542678T1 (sl) DERIVATI 1H-1,2,4-TRIAZOL-3-KARBOKSAMIDA KOT LIGANDI RECEPTORJA KANABINOIDA-CB sb 1/sb
IL186089A0 (en) 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
ZA200701518B (en) 2-(pyridin-2-yl)-pyrimidines and their use for controlling pathogenic fungi
PH12013500649A1 (en) Crystalline (r)-(e)-2-(4-(2-(5-(1-(3, 5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol and its use as fgfr inhibitor
IL195862A0 (en) 6-(heterocycle-substituted benzyl)-4-oxoquinoline compounds
IL172614A0 (en) Dual nk1/nk3 antagonists for treating schizophrenia
PT2200985E (pt) 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas
DE602004008773D1 (de) 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamin-verbindungen als beta 2-adrenoceptoren agonisten
ZA200407985B (en) 1-(4-Piperidinyl) benzimidazolones as histamine H3antagonists.
ATE522523T1 (de) 1,3,5-trisubstituiertes triazolderivat
IL194549A0 (en) 2-(pyridin-2-yl)-pyrimidines for use as fungicides
IL183647A (en) The heterocyclic compounds are converted into 3-ethylidenehydrazino
IL256489A (en) Preparations containing heterocyclic compounds for use to stimulate neurogenesis
IL179347A0 (en) 3-{4-(pyridin-3-yl)phenyl}-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
AP2383A (en) Quinoline derivatives as antibacterial agents.
ZA201103254B (en) Triazole and imidazole compounds,use thereof and agents containing them
IL179348A0 (en) 3-[4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
IL179349A0 (en) 3-[4-{6-(substituted alkanoyl)pyridin-3-yl}-3-phenyl]-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
BRPI0812257A2 (pt) Triazol[1,5-a]quinolinas como ligantes de receptores de adenosina a3.
HK1100938A (en) 3- [4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl] -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
ZA200705852B (en) 2-OXO-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-ylpiperidines used as CGRP antagonists
AP2006003506A0 (en) Parasiticidal composition.
ZA200609771B (en) 3-[4-{6-Substituted alkanoylpyridin-3-yl}-3-phenyl]-5-(1 H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
ZA200805562B (en) Azole compounds used as tuberculostatic and leishmanicide agents
GB2404587B (en) Parasiticidal composition